Healthcare & Pharmaceuticals
LATEST NEWS FROM HEALTHCARE
Healthcare & Pharmaceuticals
Sun Pharma's quarterly profit jumps on strength in specialty medicines
India's Sun Pharmaceutical Industries reported a 27% rise in first-quarter profit on Friday, driven by robust growth in its high-margin specialty medicines business as the countr...
Healthcare & Pharmaceuticals
India's Manipal Health IPO fully subscribed as institutional demand outweighs retail caution
Manipal Health Enterprises' $960.4 million initial public offering was fully subscribed on the final day of bidding on Friday, led by institutional investors, while valuation wor...
Healthcare & Pharmaceuticals
Congo's Ebola outbreak is second-largest on record, latest data shows
Democratic Republic of Congo's fast-spreading Ebola outbreak is now the world's second-largest on record, government data showed on Friday, as transmission continues to outpace ef...
Healthcare & Pharmaceuticals
Finland detects African swine fever for first time
Finland has detected African swine fever for the first time after laboratory tests confirmed the virus in a wild boar in eastern Finland, the Finnish Food Authority said in a st...
Healthcare & Pharmaceuticals
Siemens Healthineers cuts revenue forecast citing diagnostics weakness
Medical technology firm Siemens Healthineers cut its 2026 revenue growth forecast on Friday to a range of 3.5% to 4.0%, as China's procurement policy weighs on its diagnostics b...
Healthcare & Pharmaceuticals
US FDA advisers back Replimune skin cancer drug trial data
The U.S. Food and Drug Administration's panel of outside advisers on Thursday voted to back results from a trial studying Replimune's drug for a type of skin cancer.
Healthcare & Pharmaceuticals
Smallpox DNA is recovered from Spanish conquest-era Chilean mummies
When Spanish conquistadors arrived in the New World some five centuries ago, they brought muskets, cannons, armor, horses and attack dogs as they set about colonizing the Americas....
Healthcare & Pharmaceuticals
Cyclosporiasis cases in Michigan rise to 10,386 in ongoing outbreak
Michigan reported 10,386 cases linked to an outbreak of cyclosporiasis on Thursday, up 309 from its last update a day earlier.
Healthcare & Pharmaceuticals
Labcorp raises annual profit forecast on strong testing demand
Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, as steady demand for diagnostic testing and grow...
Healthcare & Pharmaceuticals
Regeneron beats quarterly estimates on eczema drug strength, shares rise
Regeneron on Thursday beat Wall Street estimates for second-quarter revenue and profit, helped by strong demand for its eczema drug Dupixent and a high-dose version of its eye dr...
Healthcare & Pharmaceuticals
Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials
Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials, paving the way for regulatory submissions seek...
Healthcare & Pharmaceuticals
UK reports rise in cyclospora infections linked to Mexico travel
The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers returning from Mexico and urged people to follow food a...
Healthcare & Pharmaceuticals
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt
Teladoc shares fell more than 20% before the bell on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental...
Healthcare & Pharmaceuticals
Bristol Myers raises 2026 forecast as Eliquis, newer medicines power results
Bristol Myers Squibb raised its full-year revenue and profit forecast on Thursday after reporting second-quarter results that came in well ahead of Wall Street estimates, driven b...
Healthcare & Pharmaceuticals
Cytokinetics wins UK approval, NICE backing for heart disease drug
Britain's medicines regulator approved Cytokinetics' drug for a rare heart condition on Thursday, with the country's cost-effectiveness watchdog recommending it for NHS reimbursem...
Healthcare & Pharmaceuticals
Braveheart Bio targets $1.2 billion valuation in US IPO
Braveheart Bio is targeting a valuation of up to $1.2 billion in its U.S. initial public offering, the clinical-stage biopharmaceutical company said on Thursday.
Healthcare & Pharmaceuticals
GSK, Relation Therapeutics sign up to $110 million AI drug discovery deal
British biotech firm Relation Therapeutics said on Wednesday it had entered into a research collaboration with GSK worth up to $110 million to generate human cellular datasets a...
Healthcare & Pharmaceuticals
Veterans' PTSD resolves with psychedelic therapy in small US study
Military veterans with post-traumatic stress disorder who got no relief from conventional treatments went into remission following treatment with the psychedelic drug psilocybin i...
Healthcare & Pharmaceuticals